These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6965983)
41. 4,4-Diphenylpiperidine derivates and their sila analogues. A comparative study of their interaction with neural receptor biding sites and synaptosomal monoamine uptake. Stasch JP; Russ H; Schacht U; Witteler M; Neuser D; Gerlach M; Leven M; Kuhn W; Jutzi P; Przuntek H Arzneimittelforschung; 1988 Aug; 38(8):1075-8. PubMed ID: 2848535 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats. Ask AL; Ross SB Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308 [TBL] [Abstract][Full Text] [Related]
43. The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes. Blough BE; Decker AM; Landavazo A; Namjoshi OA; Partilla JS; Baumann MH; Rothman RB Psychopharmacology (Berl); 2019 Mar; 236(3):915-924. PubMed ID: 30341459 [TBL] [Abstract][Full Text] [Related]
44. Conformation study of the inhibition of monoamine uptake in rat brain synaptosomes. Tuomisto J; Tuomisto L; Smissman EE Ann Med Exp Biol Fenn; 1973; 51(2):51-8. PubMed ID: 4756095 [No Abstract] [Full Text] [Related]
45. Methylaplysinopsin: a natural product of marine origin with effects on serotonergic neurotransmission. Baird-Lambert J; Davis PA; Taylor KM Clin Exp Pharmacol Physiol; 1982; 9(2):203-12. PubMed ID: 6290119 [TBL] [Abstract][Full Text] [Related]
46. Behavioral and biochemical actions of p-chlorophenylethylamine (p-CPEA) in mice. Hwang EC; Van Woert MH Life Sci; 1979 Feb; 24(7):595-601. PubMed ID: 155767 [No Abstract] [Full Text] [Related]
47. Effects of thiophene analogues of chloroamphetamines on central serotonergic mechanisms. Conde S; Madroñero R; Fernández-Tomé MP; del Río J J Med Chem; 1978 Sep; 21(9):978-81. PubMed ID: 722762 [TBL] [Abstract][Full Text] [Related]
48. Effects of fluoxetine on a specific serotonergic syndrome in rats. Keshavan HJ; Gurbani NK; Dandiya PC Indian J Med Res; 1981 Apr; 73():653-7. PubMed ID: 6973540 [No Abstract] [Full Text] [Related]
49. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice. Saavedra JM; Fischer E Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068 [No Abstract] [Full Text] [Related]
50. Structure activity correlations in the inhibition of brain synaptosomal 3H-norepinephrine uptake by phenethylamine analogs. The role of alpha-alkyl side chain and methoxyl ring substitutions. Makriyannis A; Bowerman D; Sze PY; Fournier D; de Jong AP Eur J Pharmacol; 1982 Jul; 81(2):337-40. PubMed ID: 7117379 [TBL] [Abstract][Full Text] [Related]
51. Methylaplysinopsin and other marine natural products affecting neurotransmission. Taylor KM; Baird-Lambert JA; Davis PA; Spence I Fed Proc; 1981 Jan; 40(1):15-20. PubMed ID: 6256214 [TBL] [Abstract][Full Text] [Related]
52. [Characteristics of serotonin binding by the cells of immunocompetent tissues and synaptosomes]. Eliseeva LS; Stefanovich LE; Popova VS Biull Eksp Biol Med; 1985 Aug; 100(8):210-3. PubMed ID: 4027371 [TBL] [Abstract][Full Text] [Related]
53. Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects. Rényi L; Ross SB Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):416-26. PubMed ID: 4036634 [TBL] [Abstract][Full Text] [Related]
54. Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons. Ask AL Acta Pharm Suec; 1983; 20(6):473. PubMed ID: 6675426 [No Abstract] [Full Text] [Related]
56. Evidence for a selective inhibition by FLA 336(+) of the monoamine oxidase in serotonergic neurones in the rat brain. Ask AL; Fagervall I; Ross SB Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):395-6. PubMed ID: 6184945 [No Abstract] [Full Text] [Related]
57. The effect of para-halogenated amphetamines on brain monoamines. Magyar K; Tekes K; Knoll J Pol J Pharmacol Pharm; 1978; 30(2-3):245-53. PubMed ID: 673928 [No Abstract] [Full Text] [Related]
58. Neuromuscular effects of monoamine oxidase inhibitors. Lieberman JA; Kane JM; Reife R J Clin Psychopharmacol; 1985 Aug; 5(4):221-8. PubMed ID: 3874888 [TBL] [Abstract][Full Text] [Related]
59. Para-halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms. Sloviter RS; Connor JD; Damiano BP; Drust EG Pharmacol Biochem Behav; 1980 Aug; 13(2):283-6. PubMed ID: 6447879 [TBL] [Abstract][Full Text] [Related]
60. [Phenylethylamine fluorides. II. Synthesis and neurobiochemistry in the rat]. Charlon C; Luu-Duc C; Huguet F; Gérard P; Narcisse G Farmaco Sci; 1986 Aug; 41(8):586-96. PubMed ID: 3743750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]